Piramal Pharma Limited (PPLPHARMA) — Cash Flow Reinvestment Rate
Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting Rs4.33 Billion (capex Rs4.33 Billion ) from operating cash flow of Rs8.90 Billion. See how much free cash does Piramal Pharma Limited generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Piramal Pharma Limited Cash Flow Reinvestment Rate (2021–2026)
Historical reinvestment intensity for Piramal Pharma Limited across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Piramal Pharma Limited generate cash.
Annual Cash Flow Reinvestment Rate for Piramal Pharma Limited (2021–2026)
Year-by-year capital reinvestment analysis for Piramal Pharma Limited. See PPLPHARMA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.64x | Rs8.95 Billion | Rs14.00 Billion | Rs8.90 Billion | ▼ -50.0% |
| 2025 | 1.28x | Rs11.42 Billion | Rs8.92 Billion | Rs6.64 Billion | ▲ +12.2% |
| 2024 | 1.14x | Rs11.46 Billion | Rs10.05 Billion | Rs7.12 Billion | ▼ -76.0% |
| 2023 | 4.76x | Rs23.04 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -39.6% |
| 2022 | 7.89x | Rs20.13 Billion | Rs2.55 Billion | Rs2.01 Billion | ▼ -93.8% |
| 2021 | 127.91x | Rs44.41 Billion | Rs347.20 Million | Rs581.10 Million | — |